Year |
Citation |
Score |
2016 |
Zoratti GL, Tanabe LM, Hyland TE, Duhaime MJ, Colombo É, Leduc R, Marsault E, Johnson MD, Lin CY, Boerner J, Lang JE, List K. Matriptase regulates c-Met mediated proliferation and invasion in inflammatory breast cancer. Oncotarget. PMID 27528224 DOI: 10.18632/Oncotarget.11262 |
0.71 |
|
2015 |
Duhaime MJ, Page KO, Varela FA, Murray AS, Silverman ME, Zoratti GL, List K. Cell Surface Human Airway Trypsin-Like Protease Is Lost During Squamous Cell Carcinogenesis. Journal of Cellular Physiology. PMID 26297835 DOI: 10.1002/Jcp.25173 |
0.659 |
|
2015 |
Zoratti GL, Tanabe LM, Varela FA, Murray AS, Bergum C, Colombo É, Lang JE, Molinolo AA, Leduc R, Marsault E, Boerner J, List K. Targeting matriptase in breast cancer abrogates tumour progression via impairment of stromal-epithelial growth factor signalling. Nature Communications. 6: 6776. PMID 25873032 DOI: 10.1038/Ncomms7776 |
0.703 |
|
2015 |
Boerner JL, Nechiporchik N, Mueller KL, Polin L, Heilbrun L, Boerner SA, Zoratti GL, Stark K, LoRusso PM, Burger A. Protein expression of DNA damage repair proteins dictates response to topoisomerase and PARP inhibitors in triple-negative breast cancer. Plos One. 10: e0119614. PMID 25774912 DOI: 10.1371/Journal.Pone.0119614 |
0.315 |
|
2014 |
Miller GS, Zoratti GL, Murray AS, Bergum C, Tanabe LM, List K. HATL5: a cell surface serine protease differentially expressed in epithelial cancers. Plos One. 9: e87675. PMID 24498351 DOI: 10.1371/Journal.Pone.0087675 |
0.664 |
|
2012 |
Mueller KL, Madden JM, Zoratti GL, Kuperwasser C, List K, Boerner JL. Fibroblast-secreted hepatocyte growth factor mediates epidermal growth factor receptor tyrosine kinase inhibitor resistance in triple-negative breast cancers through paracrine activation of Met. Breast Cancer Research : Bcr. 14: R104. PMID 22788954 DOI: 10.1186/Bcr3224 |
0.663 |
|
2012 |
Bergum C, Zoratti G, Boerner J, List K. Strong expression association between matriptase and its substrate prostasin in breast cancer. Journal of Cellular Physiology. 227: 1604-9. PMID 21678412 DOI: 10.1002/Jcp.22877 |
0.691 |
|
Show low-probability matches. |